• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使医学研究现代化以造福人类和动物。

Modernizing Medical Research to Benefit People and Animals.

作者信息

Hutchinson Isobel, Owen Carla, Bailey Jarrod

机构信息

Animal Free Research UK, 27 Old Gloucester Street, London WC1N 3AX, UK.

出版信息

Animals (Basel). 2022 May 3;12(9):1173. doi: 10.3390/ani12091173.

DOI:10.3390/ani12091173
PMID:35565599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9100373/
Abstract

In the context of widespread public and political concern around the use of animals in research, we sought to examine the scientific, ethical and economic arguments around the replacement of animals with New Approach Methodologies (NAMs) and to situate this within a regulatory context. We also analyzed the extent to which animal replacement aligns with British public and policymakers' priorities and explored global progress towards this outcome. The global context is especially relevant given the international nature of regulatory guidance on the safety testing of new medicines. We used a range of evidence to analyze this area, including scientific papers; expert economic analysis; public opinion polls and the Hansard of the UK Parliament. We found evidence indicating that replacing animals with NAMs would benefit animal welfare, public health and the economy. The majority of the British public is in favor of efforts to replace animals and focusing on this area would help to support the British Government's current policy priorities. We believe that this evidence underlines the need for strong action from policymakers to accelerate the transition from animal experiments to NAMs. The specific measure we suggest is to introduce a new ministerial position to coordinate and accelerate the replacement of animals with NAMs.

摘要

在公众和政治界广泛关注动物用于研究的背景下,我们试图审视围绕用新方法(NAMs)替代动物的科学、伦理和经济论据,并将其置于监管背景中。我们还分析了动物替代在多大程度上符合英国公众和政策制定者的优先事项,并探讨了在这方面的全球进展。鉴于新药安全测试监管指南的国际性质,全球背景尤为相关。我们使用了一系列证据来分析这一领域,包括科学论文、专家经济分析、民意调查以及英国议会的议会议事录。我们发现有证据表明,用新方法替代动物将有利于动物福利、公众健康和经济。大多数英国公众支持替代动物的努力,关注这一领域将有助于支持英国政府当前的政策优先事项。我们认为,这一证据凸显了政策制定者采取有力行动以加速从动物实验向新方法过渡的必要性。我们建议的具体措施是设立一个新的部长级职位,以协调并加速用新方法替代动物的进程。

相似文献

1
Modernizing Medical Research to Benefit People and Animals.使医学研究现代化以造福人类和动物。
Animals (Basel). 2022 May 3;12(9):1173. doi: 10.3390/ani12091173.
2
The 2023 Latin America report of the Countdown on health and climate change: the imperative for health-centred climate-resilient development.《2023年健康与气候变化倒计时拉丁美洲报告:以健康为中心的气候适应型发展的必要性》
Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.
3
Brazil's Regulatory Context for Using New Approach Methodologies (NAMs) on the Registration of Products.巴西在产品注册中使用新方法学(NAMs)的监管背景。
Front Toxicol. 2022 Jul 22;4:903027. doi: 10.3389/ftox.2022.903027. eCollection 2022.
4
Animal-free safety assessment of chemicals: an innovation system perspective.化学品的无动物安全评估:创新系统视角
Arch Toxicol. 2025 Jan;99(1):43-56. doi: 10.1007/s00204-024-03878-0. Epub 2024 Oct 4.
5
Culture of Care: Organizational Responsibilities关怀文化:组织职责
6
Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of industrial chemicals and pesticides for effects on human health.使用新方法学(NAMs)来满足对工业化学品和农药进行人体健康影响评估的监管要求。
Front Toxicol. 2022 Sep 1;4:964553. doi: 10.3389/ftox.2022.964553. eCollection 2022.
7
Advancing New Approach Methodologies (NAMs) for Tobacco Harm Reduction: Synopsis from the 2021 CORESTA SSPT-NAMs Symposium.推进减少烟草危害的新方法学(NAMs):2021年CORESTA SSPT-NAMs研讨会综述
Toxics. 2022 Dec 6;10(12):760. doi: 10.3390/toxics10120760.
8
The Minderoo-Monaco Commission on Plastics and Human Health.美诺集团-摩纳哥基金会塑料与人体健康委员会
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.
9
Accelerating the Pace of Chemical Risk Assessment.加速化学风险评估步伐。
Chem Res Toxicol. 2018 May 21;31(5):287-290. doi: 10.1021/acs.chemrestox.7b00339. Epub 2018 Apr 6.
10
Use of New Approach Methodologies (NAMs) in regulatory decisions for chemical safety: Report from an EPAA Deep Dive Workshop.新方法学在化学物质安全监管决策中的应用:EPAA 深度研讨会报告。
Regul Toxicol Pharmacol. 2022 Nov;135:105261. doi: 10.1016/j.yrtph.2022.105261. Epub 2022 Sep 11.

引用本文的文献

1
"Lost in translation?" Animal research in the era of precision medicine.“迷失在翻译中?”精准医学时代的动物研究。
J Transl Med. 2025 Feb 4;23(1):152. doi: 10.1186/s12967-025-06084-3.
2
In Vivo-Like Scaffold-Free 3D In Vitro Models of Muscular Dystrophies: The Case for Anchored Cell Sheet Engineering in Personalized Medicine.肌营养不良症的体内样无支架三维体外模型:个性化医学中锚定细胞片工程的应用实例
Adv Healthc Mater. 2025 May;14(12):e2404465. doi: 10.1002/adhm.202404465. Epub 2024 Dec 24.
3
Toward Transparency on Animal Experimentation in Switzerland: Seven Recommendations for the Provision of Public Information in Swiss Law.迈向瑞士动物实验的透明度:瑞士法律中关于提供公共信息的七条建议。
Animals (Basel). 2024 Jul 24;14(15):2154. doi: 10.3390/ani14152154.
4
The relevance of sustainable laboratory practices.可持续实验室实践的相关性。
RSC Sustain. 2024 Mar 18;2(5):1300-1336. doi: 10.1039/d4su00056k. eCollection 2024 May 8.
5
A Review on Alternative Methods to Experimental Animals in Biological Testing: Recent Advancement and Current Strategies.生物测试中实验动物替代方法综述:最新进展与当前策略
J Pharm Bioallied Sci. 2023 Oct-Dec;15(4):165-171. doi: 10.4103/jpbs.jpbs_380_23. Epub 2023 Dec 11.

本文引用的文献

1
Learning from the report of the independent medicines and medical devices safety review: "first do no harm".从独立药品和医疗器械安全审查报告中汲取经验:“首要之务,勿伤患者” 。
Scott Med J. 2022 Feb;67(1):2-6. doi: 10.1177/00369330211058467. Epub 2022 Jan 7.
2
Upholding the EU's Commitment to 'Animal Testing as a Last Resort' Under REACH Requires a Paradigm Shift in How We Assess Chemical Safety to Close the Gap Between Regulatory Testing and Modern Safety Science.在 REACH 法规下坚持欧盟“动物测试作为最后手段”的承诺,需要在我们评估化学品安全性的方法上进行范式转变,以缩小监管测试与现代安全科学之间的差距。
Altern Lab Anim. 2021 Jul;49(4):122-132. doi: 10.1177/02611929211040824. Epub 2021 Aug 30.
3
Continuing animal tests on cosmetic ingredients for REACH in the EU.在欧盟范围内继续对化妆品成分进行 REACH 动物测试。
ALTEX. 2021;38(4):653-668. doi: 10.14573/altex.2104221. Epub 2021 Aug 18.
4
Negative psychological aspects of working with experimental animals in scientific research.科学研究中使用实验动物进行工作的负面心理因素。
PeerJ. 2021 Apr 20;9:e11035. doi: 10.7717/peerj.11035. eCollection 2021.
5
An Estimate of the Number of Animals Used for Scientific Purposes Worldwide in 2015.2015 年全球用于科学目的的动物数量估计。
Altern Lab Anim. 2019 Nov-Dec;47(5-6):196-213. doi: 10.1177/0261192919899853.
6
Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease.有些动物模型比其他模型更平等吗?以阿尔茨海默病疗效动物模型的转化价值为例。
Eur J Pharmacol. 2019 Sep 15;859:172524. doi: 10.1016/j.ejphar.2019.172524. Epub 2019 Jul 7.
7
Does the stress inherent to laboratory life and experimentation on animals adversely affect research data?实验室环境以及动物实验所固有的压力是否会对研究数据产生不利影响?
Altern Lab Anim. 2017 Dec;45(6):299-301. doi: 10.1177/026119291704500605.
8
Motives of consumers following a vegan diet and their attitudes towards animal agriculture.消费者选择素食的动机及其对动物农业的态度。
Appetite. 2016 Oct 1;105:643-51. doi: 10.1016/j.appet.2016.06.039. Epub 2016 Jul 1.
9
Should oral gavage be abandoned in toxicity testing of endocrine disruptors?在内分泌干扰物的毒性测试中是否应摒弃经口灌胃法?
Environ Health. 2014 Jun 25;13(1):46. doi: 10.1186/1476-069X-13-46.
10
EU member state government contribution to alternative methods.欧盟成员国政府对替代方法的贡献。
ALTEX. 2014;31(2):215-8. doi: 10.14573/altex.1401061.